Evidence map›Paper›PMID 30181735›Full record

ArticleMolecular syndromology2018

A New Case of a Rare Combination of Temple Syndrome and Mosaic Trisomy 14 and a Literature Review.

Maria Yakoreva, Tiina Kahre, Sander Pajusalu, Piret Ilisson, Olga Žilina, Vallo Tillmann, Tiia Reimand, Katrin Õunap

Abstract read
In one paragraph

Article in Molecular syndromology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Linear and whorled hypermelanosis: A multicentre retrospective cohort of 33 patients.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria YakorevaDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.
Tiina KahreDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.
Sander PajusaluDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.
Piret IlissonDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.
Olga ŽilinaDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.
Vallo TillmannChildren's Clinic, Tartu University Hospital, University of Tartu, Tartu, Estonia.
Tiia ReimandDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.
Katrin ÕunapDepartment of Clinical Genetics, United Laboratories, University of Tartu, Tartu, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temple syndrome (TS14) is a relatively recently discovered imprinting disorder caused by abnormal expression of genes at the locus 14q32. The underlying cause of this syndrome is maternal uniparental disomy of chromosome 14 (UPD(14)mat). Trisomy of chromosome 14 is one of the autosomal trisomies; in humans, it is only compatible with live birth in mosaic form. Although UPD(14)mat and mosaic trisomy 14 can arise from the same cellular mechanism, a combination of both has been currently reported only in 8 live-born cases. Hereby, we describe a patient in whom only UPD(14)mat-associated TS14 was primarily diagnosed. Due to the patient's atypical features (for TS14), additional analyses were performed and low-percent mosaic trisomy 14 was detected. It can be expected that the described combination of 2 etiologically related conditions is actually more prevalent. Additional chromosomal and molecular investigations are indicated for every patient with UPD(14)mat-associated TS14 with atypical clinical presentation.

Indexed as

Imprinting disordersMaternal uniparental disomy 14MosaicismTemple syndromeTrisomy 14

Identifiers

PMID30181735
PMCPMC6117659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.